BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 23045979)

  • 1. Therapeutic potential of thymosin β4 in myocardial infarct and heart failure.
    Stark C; Taimen P; Tarkia M; Pärkkä J; Saraste A; Alastalo TP; Savunen T; Koskenvuo J
    Ann N Y Acad Sci; 2012 Oct; 1269():117-24. PubMed ID: 23045979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thymosin β4: multiple functions in protection, repair and regeneration of the mammalian heart.
    Bollini S; Riley PR; Smart N
    Expert Opin Biol Ther; 2015; 15 Suppl 1():S163-74. PubMed ID: 26094634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardioprotection by Thymosin Beta 4.
    Pipes GT; Yang J
    Vitam Horm; 2016; 102():209-26. PubMed ID: 27450736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular and cellular mechanisms of thymosin β4-mediated cardioprotection.
    Hinkel R; Trenkwalder T; Kupatt C
    Ann N Y Acad Sci; 2012 Oct; 1269():102-9. PubMed ID: 23045977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic potential of thymosin-beta4 and its derivative N-acetyl-seryl-aspartyl-lysyl-proline (Ac-SDKP) in cardiac healing after infarction.
    Cavasin MA
    Am J Cardiovasc Drugs; 2006; 6(5):305-11. PubMed ID: 17083265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac repair with thymosin β4 and cardiac reprogramming factors.
    Srivastava D; Ieda M; Fu J; Qian L
    Ann N Y Acad Sci; 2012 Oct; 1270():66-72. PubMed ID: 23050819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thymosin beta4 and Ac-SDKP: tools to mend a broken heart.
    Rossdeutsch A; Smart N; Riley PR
    J Mol Med (Berl); 2008 Jan; 86(1):29-35. PubMed ID: 17701149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thymosin beta4 and cardiac repair.
    Shrivastava S; Srivastava D; Olson EN; DiMaio JM; Bock-Marquette I
    Ann N Y Acad Sci; 2010 Apr; 1194():87-96. PubMed ID: 20536454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controlled release of thymosin β4 from injected collagen-chitosan hydrogels promotes angiogenesis and prevents tissue loss after myocardial infarction.
    Chiu LL; Reis LA; Momen A; Radisic M
    Regen Med; 2012 Jul; 7(4):523-33. PubMed ID: 22817626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thymosin β4-mediated protective effects in the heart.
    Hinkel R; Klett K; Bähr A; Kupatt C
    Expert Opin Biol Ther; 2018 Jul; 18(sup1):121-129. PubMed ID: 30063857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Biotechnological production of acetylated thymosin beta4].
    Beĭrakhova KA; Stepanenko VN; Miroshnikov AI; Esipov RS
    Bioorg Khim; 2011; 37(2):223-32. PubMed ID: 21721255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thymosin beta4 is cardioprotective after myocardial infarction.
    Srivastava D; Saxena A; Michael Dimaio J; Bock-Marquette I
    Ann N Y Acad Sci; 2007 Sep; 1112():161-70. PubMed ID: 17600280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of the cardioprotectants thymosin β4 and dexrazoxane during congenital heart surgery: proposal for a randomized, double-blind, clinical trial.
    Stromberg D; Raymond T; Samuel D; Crockford D; Stigall W; Leonard S; Mendeloff E; Gormley A
    Ann N Y Acad Sci; 2012 Oct; 1270():59-65. PubMed ID: 23050818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amniotic fluid stem cells are cardioprotective following acute myocardial infarction.
    Bollini S; Cheung KK; Riegler J; Dong X; Smart N; Ghionzoli M; Loukogeorgakis SP; Maghsoudlou P; Dubé KN; Riley PR; Lythgoe MF; De Coppi P
    Stem Cells Dev; 2011 Nov; 20(11):1985-94. PubMed ID: 21534857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thymosin
    Wang F; He Y; Yao N; Ruan L; Tian Z
    Cardiovasc Ther; 2022; 2022():1308651. PubMed ID: 35712678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of thymosin beta4 for treatment of patients with ischemic heart disease.
    Crockford D
    Ann N Y Acad Sci; 2007 Sep; 1112():385-95. PubMed ID: 17947592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controlled delivery of thymosin β4 for tissue engineering and cardiac regenerative medicine.
    Chiu LL; Reis LA; Radisic M
    Ann N Y Acad Sci; 2012 Oct; 1269():16-25. PubMed ID: 23045966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thymosin β4 protein therapy for cardiac repair.
    Dubé KN; Bollini S; Smart N; Riley PR
    Curr Pharm Des; 2012; 18(6):799-806. PubMed ID: 22236126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An Investigation on the Therapeutic Effect of Thymosin β4 and Its Expression Levels in Streptozotocin-Induced Diabetic Mice.
    Cho KS; Kim DJ; Shim B; Kim JY; Kang JM; Park SH; Lee SH; Yang HI; Kim KS
    Biomed Res Int; 2018; 2018():3421568. PubMed ID: 30225249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in the basic and clinical applications of thymosin β4.
    Goldstein AL; Kleinman HK
    Expert Opin Biol Ther; 2015; 15 Suppl 1():S139-45. PubMed ID: 26096726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.